Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 309

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 309
---
2024 to February 25, 2024 |
| 2022 April Agent warrants    |     |                      |  32 |     |                 |           33.12 |     |             | October 14, 2026                     |
| 2022 Agent warrants          |     |                      |  12 |     |                 |           78.12 |     |             | March 28, 2025                       |
| 2019 Agent warrants          |     |                      |   1 |     |                 |          193.75 |     |             | June 3, 2024                         |
|                              |     |                      | 700 |     |                 |                 |     |             |                                      |

<div align='center'>F-6 4</div>

Kintara Therapeutics, Inc. Notes to Condensed Consolidated Interim Financial Statements (Unaudited) December 31, 2023 (expressed in US dollars and in thousands, except par value and per share amounts, unless otherwise noted)

Series C Preferred Stock warrants

In connection with the Series C Preferred Stock private placement, the Company issued 2,504 Series C Agent Warrants. The Series C Agent Warrants have an exercise price of $ 1,000 per share, provide for a cashless exercise feature, and are exercisable for a period of four years from August 19, 2020. The Series C Preferred Stock issuable upon exercise of the Series C Agent Warrants is convertible into shares of common stock in the same manner as each respective underlying series of outstanding Series C Preferred Stock and will be entitled to the same dividend rights as each respective series.

The following table sets forth changes in outstanding Series C Agent Warrants:

|                                   |     | BalanceJune 30,2023 |       |     | Number ofWarrantsIssued |   |     | Number ofWarrantsExercised |   |     | Balance,December 31,2023 |       |     | Conversionprice$ |       |
| Preferred SeriesC-1Agent Warrants |     |                     | 1,929 |     |                         | — |     |                            | — |     |                          | 1,929 |     |                  | 58.00 |
| Preferred SeriesC-2Agent Warrants |     |                     |   219 |     |                         | — |     |                            | — |     |                          |   219 |     |                  | 60.70